簡要描述:錨蛋白重復結構域蛋白20A1抗體免 疫 原;KLH conjugated synthetic peptide derived from human ANKRD20A1: 631-730/823
產(chǎn)品分類
Product Category相關文章
Related Articles詳細介紹
錨蛋白重復結構域蛋白20A1抗體
產(chǎn)品名稱 | 英文名稱 | 貨號 |
錨蛋白重復結構域蛋白20A1抗體 | ANKRD20A1 | GOY-01K0202 |
商品屬性:
英文名稱: ANKRD20A1
中文名:錨蛋白重復結構域蛋白20A1抗體
別 名;A20A1_HUMAN;
ANKRD20A; ANKRD20A1; Ankyrin repeat domain 20 family member A1; Ankyrin repeat
domain 20A; Ankyrin repeat domain containing protein 20A1; Ankyrin repeat
domain-containing protein 20A1; DKFZp434A171.
研究領域;心血管 細胞生物 免疫學 神經(jīng)生物學
抗體來源;Rabbit
克隆類型;Polyclonal
交叉反應;(predicted:
Human, )
產(chǎn)品應用;WB=1:500-2000
ELISA=1:5000-10000 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:50-200 (石蠟切片需做抗原修復)
not yet tested in
other applications.
optimal
dilutions/concentrations should be determined by the end user.
理論分子量;94kDa
細胞定位;細胞膜
性 狀;Liquid
濃 度;1mg/ml
免 疫 原;KLH
conjugated synthetic peptide derived from human ANKRD20A1: 631-730/823
亞 型;IgG
純化方法;affinity
purified by Protein A
緩 沖 液;0.01M
TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
注意事項;This
product as supplied is intended for research use only, not for use in human,
therapeutic or diagnostic applications.
產(chǎn)品介紹:
Ankyrins are membrane adaptor molecules that play
important roles in coupling integral membrane proteins to the spectrin-based
cytoskeleton network. Mutations of ankyrin genes lead to severe genetic
diseases such as fatal cardiac arrhythmias and hereditary spherocytosis.
ANKRD20A (ankyrin repeat domain-containing protein 20A) is an 823 amino acid
protein that contains five ANK repeats. The gene encoding ANKRD20A maps to
chromosome 9, which consists of about 145 million bases and encodes nearly
900 genes. Considered to play a role in gender determination, deletion of the
distal portion of 9p can lead to development of male to female sex reversal,
the phenotype of a female with a male X,Y genotype. Hereditary hemorrhagic
telangiectasia, which is characterized by harmful vascular defects, and
familial dysautonomia are associated with chromosome 9. Also, chromosome 9 is
partnered with chromosome 22 in the translocation leading to the aberrant
production of BCR-ABL fusion protein often found in leukemias. |
多克隆抗體制備:
我公司合成抗原,保證陽性血清和抗體ELISA效價達到1:32000,由蛋白抗原制備的多抗,保證WB檢測結果是陽性。技術服務實行分步報價,按節(jié)點收費,為客戶節(jié)約成本。
鼠單克隆抗體制備:
客戶可根據(jù)項目實際需求情況靈活選擇進行,我公司將為您的項目提供專業(yè)的建議。在制備過程中,與客戶互動驗證,確保最終制備的抗體ELISA陽性血清檢測達到合同要求的同時,也能滿足客戶抗體最終應用驗證需求。技術服務實行分步報價,按節(jié)點收費,為客戶節(jié)約成本。
重組抗體表達服務:
重組抗體技術使制備人源化抗體和人源抗體成為可能,而這是其他常規(guī)的多克隆或單克隆抗體制備方法無法做到的。我公司已搭建好的抗體測序、重組抗體表達等先進平臺,能為客戶提供各種類型的重組抗體表達服務,包含鼠源單克隆抗體構建及表達、更換恒定區(qū)亞型的嵌合抗體表達,抗體人源化改造及表達等服務。
單項免疫學及檢測服務:
我公司也為客戶提供單項免疫學和檢測服務,如動物免疫、動物飼養(yǎng)、抗體修飾服務(如FITC,HRP等的標記)、以及ELISA,WB,IHC,DB等檢測服務。
抗體定制服務:
已注冊商標,主要用于抗體藥物發(fā)現(xiàn)和開發(fā),是我公司針對有特定應用要求和各種模型測試的客戶量身定制的專業(yè)服務,主要面向工業(yè)客戶。
產(chǎn)品咨詢
歡迎您關注我們的微信了解更多信息
電話
微信掃一掃